FLGT · Company research
Fulgent Genetics, Inc. Common Stock (FLGT): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
13records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| $FLGT stock is down 9% today. Here's what we see in our data. - Quiver Quantitative | $FLGT stock is down 9% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 6, 2026 | neutral | 0 | 0.6 |
| Fulgent Genetics (NASDAQ:FLGT) Shares Down 6.5% - Time to Sell? - MarketBeat | Fulgent Genetics (NASDAQ:FLGT) Shares Down 6.5% - Time to Sell? MarketBeat | View source ↗ | MarketBeat | Oct 6, 2026 | neutral | 0 | 0.6 |
| Fulgent Genetics (NASDAQ: FLGT) officer to sell 45,304 vested shares for taxes - Stock Titan | Fulgent Genetics (NASDAQ: FLGT) officer to sell 45,304 vested shares for taxes Stock Titan | View source ↗ | Stock Titan | Sep 2, 2026 | neutral | 0 | 0.6 |
| Fulgent Genetics (FLGT) officer plans stock sale to cover taxes - Stock Titan | Fulgent Genetics (FLGT) officer plans stock sale to cover taxes Stock Titan | View source ↗ | Stock Titan | Sep 2, 2026 | neutral | 0 | 0.6 |
| Fulgent Genetics (FLGT) Stock Price Slides As Losses Deepen Guidance Falls - Simply Wall Street | Fulgent Genetics (FLGT) Stock Price Slides As Losses Deepen Guidance Falls Simply Wall Street | View source ↗ | Simply Wall Street | Aug 1, 2026 | neutral | 0 | 0.6 |
| Fulgent Genetics, Inc. (FLGT) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance | Fulgent Genetics, Inc. (FLGT) Reports Q2 Loss, Misses Revenue Estimates Yahoo Finance | View source ↗ | Yahoo Finance | Jul 30, 2026 | neutral | 0 | 0.6 |
| Fulgent Genetics (FLGT) Releases Q2 2026 Earnings: Revenue Growth but EPS Miss - Quiver Quantitative | Fulgent Genetics (FLGT) Releases Q2 2026 Earnings: Revenue Growth but EPS Miss Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 30, 2026 | neutral | 0 | 0.6 |
| Fulgent Genetics: Strong Moves By Management Keep Me Bullish (NASDAQ:FLGT) - Seeking Alpha | Fulgent Genetics: Strong Moves By Management Keep Me Bullish (NASDAQ:FLGT) Seeking Alpha | View source ↗ | Seeking Alpha | Jul 13, 2026 | neutral | 0 | 0.6 |
| Fulgent to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026 - Business Wire | Fulgent to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026 Business Wire | View source ↗ | Business Wire | Jul 9, 2026 | neutral | 0 | 0.6 |
| FLGT Forecast — Price Target — Prediction for 2027 - TradingView | FLGT Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
| Lowey Dannenberg, P.C. is Investigating Fulgent Genetics - GlobeNewswire | Lowey Dannenberg, P.C. is Investigating Fulgent Genetics GlobeNewswire | View source ↗ | GlobeNewswire | May 22, 2026 | neutral | 0 | 0.6 |
| Fulgent Genetics, Inc. Common Stock (FLGT) Stock Price: Oct 7 Close $20.57 - Gotrade | Fulgent Genetics, Inc. Common Stock (FLGT) Stock Price: Oct 7 Close $20.57 Gotrade | View source ↗ | Gotrade | Mar 7, 2026 | neutral | 0 | 0.6 |
| Assessing Fulgent Genetics (FLGT) Valuation After Earnings Outperformance And AI Oncology Pipeline Progress - Simply Wall Street | Assessing Fulgent Genetics (FLGT) Valuation After Earnings Outperformance And AI Oncology Pipeline Progress Simply Wall Street | View source ↗ | Simply Wall Street | Mar 2, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.